- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/645 - Secretins
Patent holdings for IPC class C07K 14/645
Total number of patents in this class: 52
10-year publication summary
|
5
|
4
|
7
|
7
|
2
|
4
|
3
|
9
|
6
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eli Lilly and Company | 4106 |
5 |
| Antag Therapeutics ApS | 13 |
5 |
| Novo Nordisk A/S | 2283 |
4 |
| Adda Biotech Inc. | 6 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 628 |
3 |
| Shattuck Labs, Inc. | 120 |
3 |
| Hanmi Pharm. Co., Ltd. | 602 |
2 |
| Indiana University Research and Technology Corporation | 783 |
2 |
| University of Copenhagen | 439 |
2 |
| Zealand Pharma A/S | 269 |
2 |
| Shanghai Minwei Biotechnology Co., Ltd | 11 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6656 |
1 |
| The Trustees of Columbia University in the City of New York | 3648 |
1 |
| Amylyx Pharmaceuticals Inc. | 125 |
1 |
| Bolder Biotechnology, Inc. | 14 |
1 |
| CEM Corporation | 103 |
1 |
| Eiger BioPharmaceuticals, Inc. | 32 |
1 |
| Han, Jie | 9 |
1 |
| Innovation Ulster Limited | 18 |
1 |
| Jiangnan University | 1635 |
1 |
| Other owners | 10 |